Among them, human sarcoma is of particular interest because the p53 gene in this type of cancer is usually not mutated [1], implicating UXT-dependent p53 inhibition as a novel mechanism of p53 inactivation in human sarcoma. This evidence concerns the gene UXT and sarcoma.